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Abstract
Background: Once effective therapy for a previously untreatable condition is made available, a
normalisation of the disease often occurs. As part of a broader initiative to monitor the
implementation of the national antiretroviral therapy (ART) programme, this qualitative study
investigated the impact of ART availability on perceptions of HIV in a rural ward of North Tanzania
and its implications for prevention.
Methods: A mix of qualitative methods was used including semi-structured interviews with 53
ART clinic clients and service providers. Four group activities were conducted with persons living
with HIV. Data were analyzed using the qualitative software package NVIVO-7.
Results: People on ART often reported feeling increasingly comfortable with their status reflecting
a certain "normalization" of the disease. This was attributed to seeing other people affected by HIV,
regaining physical health, returning to productive activities and receiving emotional support from
health service providers. Overcoming internalized feelings of shame facilitated disclosure of HIV
status, helped to sustain treatment, and stimulated VCT uptake. However "blaming" stigma - where
people living with HIV were considered responsible for acquiring a "moral disease" - persisted in
the community and anticipating it was a key barrier to disclosure and VCT uptake. Attributing HIV
symptoms to witchcraft seemed an effective mechanism to transfer "blame" from the family unit to
an external force but could lead to treatment interruption.
Conclusion: As long as an HIV diagnosis continues to have moral connotations, a de-
stigmatisation of HIV paralleling that occurring with diseases like cancer is unlikely to occur.
Maximizing synergies between HIV treatment and prevention requires an enabling environment for
HIV status disclosure, treatment continuation, and safer sexual behaviours. Local leaders should be
informed and sensitised and communities mobilised to address the blame-dimension of HIV stigma.
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Background
Historically, sexually transmitted infections like syphilis
have been feared, considered as "invaders of the commu-
nity", attributed to a "spoilt identity" [1] and perceived as
a deserved punishment. Other infectious diseases like lep-
rosy have also been feared [2], especially if they led to pro-
gressive physical deterioration [3,4] or as in the case of
cholera, if related to sudden death and accompanied by
"un-dignifying" symptoms [5]. Untreatable non-infec-
tious diseases have also been heavily stigmatised due to
their association with an unavoidable death. However, as
the case of cancer shows, stigmatised diseases previously
seen as a "death sentence" tend to be progressively per-
ceived as "any another disease" and to "normalise", once
effective therapy is made available [5].
Following this logic, the provision of antiretroviral ther-
apy (ART) in resource-poor settings was expected to miti-
gate stigma by turning AIDS into a manageable condition,
subsequently leading to improved rates of disclosure and
HIV testing [6,7], and ultimately to safer sexual behav-
iours. Experiences in resource-poor settings have indeed
demonstrated the potential of treatment availability to
reduce stigma and strengthen HIV prevention [8-10].
However, stigma continues to be a crucial barrier to HIV
status disclosure [11-13], treatment adherence [13-15]
and uptake of voluntary counselling and testing (VCT)
[16-22]. This is of particular relevance in the context of
generalised epidemics in sub-Saharan Africa where 22
million people live with HIV/AIDS [23], most of whom
are unaware of their own and their partner's HIV status
[24,25], and where between 45% and 75% of married
HIV-positive individuals have HIV-negative spouses
[26,27].
While theoretical approaches to understanding HIV-
related stigma have received substantial attention in the
literature [28-31], few empirical studies have explored the
impact of ART availability on different forms of stigma in
resource-poor settings. As part of a broader study explor-
ing attendance rates at an ART clinic in a semi-rural ward
of northern Tanzania [32,33], this study investigated the
impact of ART provision on perceptions of HIV and its
implications for prevention.
Theoretical framework
Early work considered stigma as a "discrediting attribute"
enacted through interpersonal interactions which spoiled
and devaluated an individual's social identity [1,34].
However, "labelling" interpretations of stigma as an indi-
vidual's static characteristic or "undesirable difference"
have led to interventions focused at the individual level
which overlook social and structural determinants such as
the role of families, communities, national polices and
the economic context [31,35]. Broader frameworks that
question restrictive interpretations of Goffman's work and
incorporate Foucault's reflections on culture, power, and
the "social production of difference" have been proposed.
These consider stigma as a social process used by individ-
uals, communities and the state to produce and reproduce
relations of power and control [28]. Stigma thus becomes
part of a complex "struggle for power" and can serve as a
form of "social psychological policing" [36] aimed at per-
petuating the advantage of some groups in favour of oth-
ers, legitimizing hierarchies and inequalities of class, race,
gender and sexuality [28].
Drawing from the conceptual work of Deacon, we under-
stand stigma as a culturally constructed and constantly
changing social process, through which people project
blame onto "out groups" in an emotional response to per-
ceived danger [30]. This process, originating in the desire
to avoid diseases [37], creates boundaries between the
"normal" and those posing moral and health threats to
the majority, and in certain circumstances, may be used as
an instrument to maintain the "social order"
[28,30,38,39]. Using the recent typology developed by
Phelan and colleagues, we consider that stigma is based
on both "disease avoidance" (keeping them away) and
"norm enforcement" (keeping the rest in) [40].
Based on distinctions made between the "emic" or
insider's perspective and the "etic" view of outsiders [41],
we differentiate enacted stigma or discrimination from self-
stigma, defined as the internalised feelings of shame
resulting from accepting others' judgments over one's
identity [1,30] which often lead to constricted social net-
works [13], low self-esteem, and hopelessness [29,42].
Anticipated stigma will be understood as the reactions peo-
ple expect from others if it were to become known that
they were living with HIV [30]. Stigma can be projected
onto those closely related to people living with HIV/AIDS
(PLHA) such as family members who may share the
shame and blame attached to those infected (secondary
stigma) [29,43] and such layered disadvantage can lead to
multiplying stigma [44].
As for the sources of stigma, we differentiate between 1)
burden-related stigma, derived from the inability of indi-
viduals to conduct productive activities and look after
themselves, 2) blame-related stigma, resulting from the
association of PLHA with negatively-defined behaviours
and 3) stigma derived from the fear of being infected by
HIV through casual or sexual contact [30,45].
For the purpose of this study we define "HIV normalisa-
tion" as a process closely linked to the existence of effec-
tive treatment [46] whereby persons living with HIV feel
progressively re-integrated into productive and social life.
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Study setting
Data collection took place in Kisesa ward, in Magu dis-
trict, where a community-based cohort study, operating in
this community since 1994, is currently monitoring the
implementation of the national ART programme. Kisesa
has a population of approximately 29,000 inhabitants
and consists of five dispersed villages and a trade centre
along the main road from Mwanza city to the Kenyan bor-
der. Farming and petty business are the main economic
activities and the income per capita is below 120 USD per
year. Traditional religions are followed by 23% of the
population, while 74% are Christian and 3% are Muslim.
Over 37% of deaths among individuals above 15 years of
age are attributed to HIV/AIDS in this community and
HIV prevalence was estimated at 7.4% in 2006/7.
Since 2003, VCT services have been available from tempo-
rary village-based facilities provided during HIV surveil-
lance rounds which are conducted every two-three years.
VCT services have additionally been available from a per-
manent clinic located in the trade centre since 2005.
Referrals to the ART clinic, located in Mwanza city, about
half an hour's drive away, have been facilitated by these
VCT services since the beginning of the national HIV treat-
ment programme in 2005. Eligibility criteria for treatment
initiation include disclosure of HIV status to at least one
"treatment supporter" and being registered with a com-
munity-based organisation (CBO) providing home-based
care services (HBC) in the ward.
Methods
Qualitative tools were used including semi-structured
interviews with 42 clients and 11 HIV service providers
from the ART Clinic, the VCT clinic and the CBO provid-
ing HBC services in the ward (Tables 1 and 2). Four par-
ticipatory activities were conducted with members of a
post-test support group (Table 3) using visual tools to
identify and rank barriers to clinic attendance. A sampling
frame was constructed that consisted of all Kisesa resi-
dents who had registered at the ART clinic. Participants
were then purposively selected to broadly reflect the com-
position of the study population in terms of sex, area of
residence, ART status and adherence to clinic appoint-
ments, as shown in table 1.
The VCT counsellors and HBC providers delivered the
interview invitations to their clients during counselling
sessions or home visits, while the invitation to participate
in the group discussion was made during a scheduled
meeting of the post-test club. All invited individuals were
Table 1: Characteristics of the sampling frame and ART clinic clients undertaking semi-structured interviews
In sampling frame Interviewed
Variable Category N n (%)
Total 66 42 (64)
Sex Male 20 14 (70)
Female 46 28 (61)
Age 15-24 4 2 (50)
25-34 29 21 (72)
35-44 22 16 (73)
45+ 11 3 (27)
Area of residence Remote rural 16 11 (69)
Roadside 50 31 (62)
ART status On ART (no interruptions) 33 21 (64)
On ART (at least 1 interruption > 1 month) 4 4 (100)
Not yet started ART 29 17 (59)
Number of missed appointments
(pre- and post-ART initiation)
0 34 21 (62)
1 13 10 (77)
2 10 6 (60)
>2 9 5 (56)
Period referred from VCT Mar 05 -Sep 05 28 17 (61)
Sep 05 -Feb 06 10 7 (70)
Mar 06 -Sep 06 28 18 (64)
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informed about the overall aims of the study and its meth-
ods.
Prior to starting the interviews, participants were
informed that they could stop at any time and choose not
to answer any of the questions. In order to minimise dis-
tress, group discussions focused on the expected experi-
ences of a "hypothetical community member" while
accessing HIV services, rather than the specific experiences
of the participants. Consent was obtained and tape
recorded at the beginning of each interview and was ver-
bally obtained from each person participating in the
group discussions. (see additional file 1).
Participants were not offered any economic incentive
beyond a payment of 2000 Tanzanian shillings (equiva-
lent to ~2 USD) to compensate for their time and trans-
port costs. Interviewers and group discussion facilitators
received training that was specific to the sensitive nature
of the topic, and which also covered ethical issues such as
confidentiality. To ensure anonymity, codes were used for
identifying participants on all tapes and transcripts. At the
end each activity participants were informed about the
availability of supportive counselling services provided at
the VCT clinic and were given detailed information about
HIV and how to access the ART clinic. Ethical approval
was obtained from both the London School of Hygiene
and Tropical Medicine and the Tanzanian Medical
Research Coordinating Committee.
All the interviews were recorded after permission was
granted, and the data were subsequently transcribed and
translated into English. For the group activities, detailed
notes were taken by one of the researchers. Data were ana-
lyzed with the qualitative software package NVIVO-7
using a social ecological framework as an initial coding
guide to identify manifestations of HIV-related stigma at
interpersonal, community, and wider social levels [47-
49]. This was followed by detailed analysis of the main
types (enacted, internalised, anticipated, secondary) and
sources of stigma (fear, blame, burden) conceptualised in
the existing literature [30]. Respondents were classified by
demographic variables which allowed us to explore pat-
terns by gender, residence and age. To maximise rigour,
the interpretations were validated by a second researcher
who independently coded the data and emerging hypoth-
eses were tested by actively seeking counter examples or
"dissenting voices".
Results
Decreased internalized stigma
A process of reduced self-stigma was frequently experi-
enced by ART users participating in this study. Reports
about "feeling like an ordinary person" were often
expressed by both men and women and especially by res-
idents of the trade centre.
"I just felt good because this disease has now become like an
ordinary disease" (female, roadside area)
The actual or expected positive outcomes derived from
being on ART played a major role in helping individuals
to overcome internalised feelings of shame ("aibu").
"... you will stop being embarrassed. Do you want me to
die? So you stop feeling shame. You do away with shyness"
(group activity, females from roadside areas)
The increased public profile of PLHA in the media and
interaction with other patients at the ART clinic contrib-
uted to greater awareness about how widespread the dis-
ease was and to a comforting realisation of "not being the
only one".
"I see that just as usual...because I am not the only one...it
is not at one family. Now it is the whole of Tanzania"
(female, roadside area)
Table 2: Characteristics of service providers undertaking semi-
structured interviews
Type of service provider n
VCT Counsellors 2
Registration nurses 2
Adherence counsellors 1
Tracing nurse 1
Home-based care providers 3
ART Doctor 2
Sex
Females 9
Males 2
Table 3: Characteristics of participants in group activities
Group 1 Men, road-side areas (n = 11)
Group 2 Men, remote areas (n = 6)
Group 3 Females, road-side areas (n = 18)
Group 4 Females, remote areas (n = 11)
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"It's not me alone. There are so many people too. In fact
they are many. Others are even older that I am. Ee, it's
many, you see, so I continued encouraging myself"
(female, roadside area)
In addition to acknowledging the significant numbers
sharing the experience of HIV, participants highlighted
their growing awareness that AIDS could affect a wide
range of community members, including people deemed
"innocent" and "respectable", which presumably indi-
cated those who did not exhibit characteristics or behav-
iour usually associated with the shame ascribed to the
disease.
"Later I perceived it to be just normal. Normal...because
this is not a disease that's perhaps to me alone. You see it
advertised on newspapers, it takes even the members of par-
liament and we see it" (male, roadside area)
"I felt just better because at the beginning we hadn't seen
such a number of children also having the virus while they
don't even know about sexual matters or anything"
(female, roadside area)
Respondents also identified emotional support from
health service providers and other ART users as playing a
significant role in easing anxiety and treating HIV as any
other manageable disorder found in the community.
"Many patients come here stigmatizing themselves psycho-
logically. We explain and educate them... after they see that
crowd of people they agree and even apologize: 'I thought it
was only me, but this problem is just normal and we are
many"' (service provider, ART clinic)
"The doctor told me: 'you have been infected with the dis-
ease'. After I received good instructions it encouraged me. I
stopped worrying. It's when I got courage that I should per-
ceive it to be just a normal thing" (female, roadside area)
"We reassure the patients that there is no problem: 'there
are so many people like you. This service is like the service
on diabetes, heart patients'..." (service provider, ART
clinic)
This process of "normalisation" had three demonstrable
positive outcomes: (1) facilitating HIV status disclosure,
(2) stimulating VCT uptake, and (3) helping ART users
cope with enacted stigma and sustain treatment.
Some study participants mentioned that they had dis-
closed to family members only after having initiated ther-
apy and a few described how the "normalisation" of HIV
had facilitated the process of disclosure and their accept-
ance within their own families.
"I felt that I should involve my relatives. I told my brother,
my father. I also told my sister-in-law. She told me that I
should just be calm, 'you just get treatment, this has become
just like fever, you shouldn't look back"' (female, roadside
area)
"...after returning there (ART clinic) I started involving her
(wife). We would go there often with her and other patients
and I would show her: 'all these are suffering from the same
disease'... gradually she started perceiving it to be just nor-
mal" (male, roadside area)
"He (brother) just gave me hope because I am not the only
one. There are just many people who are in that condition
and they are continuing to live. There is hope because being
affected is not the end of life" (male, roadside area)
"The catastrophe is now for everybody, I can't keep it to
myself, I have to tell my relatives... They just said that this
disease is now a disease for all the people" (female, road-
side area)
For some however, the fear of admitting their status per-
sisted and reflected the very real negative consequences
that could ensue:
"I told him and he said: if you are in that condition then
we will have to separate" (female, remote rural area)
The positive effects of initiating therapy and the reduction
of internalized stigma led some ART users to successfully
advise others to undergo HIV testing and initiate treat-
ment.
"I had to tell him/her because you know there is no problem.
S/he said I will go to check too" (male, remote rural area)
"A neighbour told me that he had been using them for a
long period. He took me there...I started using these drugs
and until now I am continuing using them" (female, road-
side area)
Finally, many clients reported how the reduction of inter-
nalized stigma helped them cope with community-level
stigma and sustain treatment.
"You just ignore them. You know you are sick. Why should
you listen to him/her? You have only to ignore him/her.
What I care is only to go to get the drugs. Let him/her
talk...definitely they will say something but I will just con-
tinue taking the drugs" (female, roadside area)
Persistence of enacted and anticipated stigma
In spite of the reduction of internalised stigma and the
trend towards a "normalisation" of HIV, participants
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sometimes referred to having been excluded, mocked,
feared and blamed by members of their community. AIDS
was still perceived as an avoidable "moral disease" associ-
ated with unacceptable sexual behaviour and PLHA were
consequently judged to be personally responsible for con-
tracting HIV. While burden-related stigma as well as the
fear of HIV transmission through casual contact had
decreased, blame-related stigma persisted in spite of the
generalised epidemic and the availability of ART.
Only a few cases reported experiencing severe stigma at
home compared to those reporting discrimination from
community members. However, when stigma was experi-
enced within the family, its consequences could be harder
to overcome and even result in treatment interruption.
Participants often referred to a wide range of attitudes
towards PLHA in this community, with this heterogeneity
making it difficult for them to predict the stigma they
might face in the event of disclosure. The unpredictable
nature of these responses contributed to persistently high
levels of anticipated stigma, and prevented some partici-
pants from disclosing their HIV status.
"You find some pointing a finger at you: 'that one has
AIDS', they are stigmatizing us, but others see it just as
malaria fever" (female, roadside area)
"I didn't tell anyone...because I felt that if I will tell some-
one, most of the people are not good, there are some who
will keep on talking things about you. There are others who
may see that as something strange, another may feel sad for
someone. You can't know" (male, remote rural area)
Anticipated stigma contributed to explaining the resist-
ance of some family members to accept the HIV status of
a relative. Witchcraft seemed to be a more sociably accept-
able explanation for the disease and a few people believed
that HIV could be cured through prayers. Family-level
"denial" could heavily influence individuals' health-seek-
ing behaviour, preventing HIV testing and even leading to
attrition from the ART program.
"...that family isolated him/her. They used to attend him/
her thinking that s/he was bewitched but since then I have
to attend him/her myself" (service provider, HBC organ-
isation)
"My husband suffered and his relatives took him to tradi-
tional medicines...I begged him till he agreed (to test), his
relatives were refusing"(female, roadside area).
"He/she comes to tell you again: 'I was told at home...that
I should not go to hospital but I should go to church"' (serv-
ice provider, HBC organisation)
Condom use was stigmatised by association with illicit
sexual activity, providing evidence of the widespread per-
ception that HIV was a result of degrading behaviour.
"If you tell a woman about condom. she will think that you
have regarded her to be garbage" (male, roadside area)
Finally, it is worth highlighting occasional reports that
pointed to ART availability as a factor that could poten-
tially feed into existing community-level stigmatisation of
PLHA as a consequence of their regained health and per-
ceived increase in sexual activity.
"I just used to hear that they have brought medicines for
increasing life, now that fear: why do they bring us those
medicines? People taking them will continue to do evils and
spread it. But I didn't know that I too was infected" (male,
roadside area)
Discussion
Our data suggest that a decrease in self-stigma is experi-
enced by ART users reflecting a certain "normalisation" of
the disease. By seeing lots of other people affected during
visits to the clinic, as well as regaining physical health,
engaging in productive activities and receiving emotional
support from health service providers and family mem-
bers, ART users tend to progressively perceive HIV as "an
ordinary disease" which affects many other "normal peo-
ple". (Figure 1)
As initially hypothesized, the provision of HIV treatment
has thus had a powerful impact on the stigma felt by many
ART users. This can facilitate HIV status disclosure, stimu-
late VCT uptake and lead to safer sexual behaviours [8,9].
Overcoming internalised stigma also helps to cope with
enacted stigma and sustain treatment, which in turn leads
to lower infectiousness [50,51] further maximising poten-
tial synergies between HIV treatment and prevention [52].
However, in spite of reduced internalised stigma reported
by most ART users, attitudes towards PLHA in the com-
munity were very heterogeneous and discrimination pre-
vailed. The "blame" discourse behind enacted stigma was
only marginally affected by ART availability and the
deeply rooted association of HIV/AIDS with shameful and
avoidable behaviour persisted. Research conducted in the
same study setting points to the emergence of new sources
of stigma associated with the perception that people on
antiretroviral treatment could contribute to the ongoing
spread of the disease. [53]
Our findings suggest that ambivalent and heterogeneous
attitudes towards PLHA result in high levels of anticipated
stigma, which may prevent HIV status disclosure. Associa-
tions between anticipated stigma and non-disclosure [54]
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help to explain why barriers to disclosure persist in spite
of antiretroviral availability [11-13]. The lack of a correla-
tion between being on ART and disclosing HIV status
identified in other studies [55] is of particular relevance
considering the potential increase of sexual activity
among ART users as their health improves [56,57] and the
strong associations found between non-disclosure, higher
risk behaviours [58], lower adherence [59,60], and treat-
ment failure [61].
Denial of HIV status also appeared to be linked to antici-
pated stigma and could lead to treatment interruption.
The limited impact of ART provision on the "blame"
dimension of stigma, seemed to make healing alternatives
such as "being prayed for" and causal explanations such as
"being bewitched" more acceptable. The latter might partic-
ularly affect family members wishing to switch the burden
of "shame and blame" away from the family by attribut-
ing the disease to an uncontrollable force like the deliber-
ate action of witches rather than to the "immoral and
avoidable behaviour" of a family member. Similarly, not
testing for HIV would be an effective strategy to perpetuate
ambiguity over the real causes of the syndrome.
Our findings suggest that the "moral exploitation" of HIV
as a tool used by some groups to distance them from per-
ceived risk and police the behaviours of others might pre-
vent the benefits of ART from being maximised. The
potential positive effects of ART provision on status dis-
closure, viral load reduction, and VCT uptake risk being
eroded by persistent blaming attitudes that lead to high
levels of anticipated stigma and contribute to HIV denial.
Stigma projected onto condoms and recent moves
towards the criminalisation of sexual and vertical trans-
mission of HIV in a number of sub-Saharan African coun-
tries further undermine the potential of ART provision to
contribute to prevention efforts [62].
While health service providers can effectively contribute
to tackling internalised and enacted stigma [35], anti-
stigma interventions should target PLHA as well as their
families if the full public health benefits of ART roll-out
are to be realised. Local leaders should be informed and
sensitised and communities mobilised to address the
blame-dimension of HIV stigma. Sharp increases in VCT
uptake took place in Tanzania, after government person-
alities tested for HIV in July 2007 [63]. This demonstrates
that opinion leaders can effectively influence values and
contribute to a reduction of stigma by emphasizing that
HIV is not a "deserved punishment" but a "normal dis-
ease" that can affect anyone.
The underlying causes of stigma are similar across a wide
diversity of countries and continents [29]. However, cau-
tion is needed before generalizing our results. The small
sample size that characterises qualitative studies poses cer-
tain limits to the extrapolation of our findings, particu-
larly when we take into account that individuals accessing
Impact of ART provision on HIV "normalisation"Figure 1
Impact of ART provision on HIV "normalisation".
N
or
m
al
is
at
io
n 
of
 H
IV
A
R
T
 p
ro
vi
si
on
 
INCREASED SOCIAL 
 SUPPORT 
(Health providers, family 
members) 
INCREASED PUBLIC 
PROFILE OF PLHA  
(ART clinic, post-test clubs, 
media) 
“I am not the only one”
“this is like the service 
of diabetes” 
PHYSICAL 
RECOVERY  
(Returning to productive 
activities)  
“It has become the 
same as fever”
BMC International Health and Human Rights 2009, 9:22 http://www.biomedcentral.com/1472-698X/9/22
Page 8 of 10
(page number not for citation purposes)
the ART clinic during the two first years of availability
might be those who were most motivated and in the most
favourable circumstances. The small study sample also
limits our ability to identify patterns by sex and age. Fur-
thermore, positive experiences might have been over-
reported due to "courtesy bias". Finally, while the attribu-
tion of HIV disease to witchcraft is common in rural Africa
[64-66] and a tendency to "hide behind witchcraft" has
been identified elsewhere [67], AIDS symptoms may also
be attributed to ancestors who "punish an individual for
having transgressed". As even traditional beliefs in ances-
tral powers may attribute a certain level of blame to
affected individuals, HIV education needs to counter
stigma whatever its source [68].
This study was limited to clients' and HIV service provid-
ers' perceptions and additional research is required to
explore the social consequences of ART scale-up from a
wider community perspective. Perceived and actual
changes in the sexual behaviours of PLHA need particular
attention. In the long run, if the widespread use of antiret-
roviral drugs has a significant impact on viral load levels
and on users' infectiousness, this may also become appar-
ent in the community and have a substantial impact on
stigma.
Conclusion
As long as a HIV diagnosis continues to carry moral con-
notations, widespread de-stigmatisation of HIV mirroring
that of diseases like cancer is unlikely to occur. The poten-
tial positive effects of ART provision on status disclosure,
viral load reduction, and VCT uptake are at risk of being
eroded by persistent blaming attitudes. Key community
stakeholders should be identified, trained and sensitised
to tackle the blame-dimension of HIV stigma and create
an enabling environment for HIV disclosure, treatment
continuation, and safer sexual behaviours.
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